The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

Shares plummeted by almost eight percent on Wednesday, with Zepbound and diabetes drug Mounjaro — the active ingredient in ...

There's buzz around certain type 2 diabetes drugs, which not only help regulate blood sugar but can also lead to significant ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

The South African Health Products Regulatory Authority (SAHPRA) has expressed concern at the increasing presence of counterfeit Glucagon-like Peptide (GLP-1) products, such as Ozempic, on the local ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Shares plummeted by almost eight percent on Wednesday, with Zepbound and diabetes drug Mounjaro — the active ingredient in both is tirzepatide, a GLP-1 receptor agonist — missing Wall Street ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs ... Last month, the FDA said ...

The FDA has also warned that some compounders may be selling salt forms of semaglutide, which contain different active ingredients, and that counterfeit forms of Ozempic are being sold. Semaglutide ...